[Hemosorption as a method of unblocking immunotherapy].
Hemosorption was carried out in 34 cancer patients. Levels of circulating immune complexes, blastogenic reaction of lymphocytes and E--RFC concentration were assayed before and after treatment. Hemosorption was followed by a significant decrease in circulating immune complex level and an improvement in cell-mediated immunity, which appeared to be in correlation with immediate clinical effect. Thus, hemosorption should be regarded as a deblocking therapy procedure.
D000328:Adult; D000368:Aged; D000936:Antigen-Antibody Complex / Q000032:analysis; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D007111:Immunity, Cellular; D007167:Immunotherapy / Q000379:methods*; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012397:Rosette Formation
D000936:Antigen-Antibody Complex
Gemosorbtsiia kak metod deblokiruiushcheĭ immunoterapii.